Siatkowski RM | 2001 | 32 F | Systemic lupus erythematosus | OU | 6 months of corticosteroid | 3 relapses on corticosteroid | Monthly IV cyclophosphamide for 7 months, no relapses while on therapy | Unknown | Unknown | OD:LP OS:20/15 | OD:5/200 OS:20/200 | Patient discontinued cyclophosphamide because she desired to become pregnant. |
| | 42 F | | OD | Unknown | Unknown | Azathioprine for 16 months, then monthly IV cyclophosphamide | Unknown | 20 mg | OD:20/200 | OD:20/40 | |
Frohman LP | 2001 | 51 F | Systemic lupus erythematosus | OU | 5mg/2.5 mg and hydroxychloroquine 400 mg daily | Unknown | Methotrexate 15 mg weekly | Unknown | 0 mg | OD:LP OS:20/70 | OD:20/20 OS:20/20 | |
Galindo-Rodriguez G | 1999 | 41 F | Systemic lupus erythematosus | OU | 100 mg for 2 months | Disease refractory to corticosteroid and/or oral immunosuppression | Cyclophosphamide 0.5–1.0 gm/m2 IV on 2 consecutive days monthly. Mean duration 5 months | All patients had side effects: 7 patients with urinary tract infections, 3 patients with upper respiratory infections, 2 patients with herpes zoster infections, 1 patient with pneumonia, 4 patients with oral candidaisis, 5 patients with hair loss, 1 patient with cutaneous abcess. | Unknown | OD:20/40 OS:HM | OD:20/30 OS:20/30 | Only 3 patients discontinued treatment and this was secondary to nausea and vomiting. |
| | 35 F | | OU | 100 mg for 4 months | | | | | OD:CF OS:CF | OD:20/50 OS:20/100 | |
| | 36 F | | OU | 60 mg for 8 months and azathioprine 150 mg for 9 months and cyclophosphamide by mouth for 12 months | | | | | OD:CF OS:CF | OD:20/50 OS:20/20 | |
| | 18 F | | OU | 60 mg for 24 months and azathioprine 100 mg for 24 months and cyclophosphamide by mouth for 6 months | | | | | OD:NLP OS:CF | OD:CF OS:20/200 | |
| | 44 F | | OU | 100 mg for 4 months and azathioprine 150 mg for 20 months and cyclophosphamide by mouth for 4 months | | | | | OD:CF OS:CF | OD:20/25 OS:20/30 | |
| | 55 F | | OU | 100 mg for 2 months | | | | | OD:20/70 OS:20/70 | OD:20/20 OS:20/20 | |
| | 43 F | | OU | 100 mg for 2 months | | | | | OD:CF OS:CF | OD:20/60 OS:20/80 | |
| | 17 F | | OU | 100 mg for 3 months and azathioprine 100 mg for 2 months | | | | | OD:CF OS:CF | OD:20/20 OS:20/25 | |
| | 32 F | | OU | 150 mg for 4 months | | | | | OD:HM OS:20/40 | OD:HM OS:20/60 | |
| | 30 F | | OU | 60 mg for 1 month | | | | | OD:20/20 OS:20/25 | OD:20/30 OS:20/40 | |
Rosenbaum JT | 1997 | 32 F | Systemic lupus erythematosus | OS | Unknown doses of corticosteroid and azathioprine | Unknown | IV cyclophosphamide for 28 months | Unknown | Unknown | OD: HM | OD: 20/20 | |
| | 56 F | | OD | Unknown dose | | IV cyclophosphamide for 2 months | | | OD: LP | OD: 20/30 | |
Maust HA | 2003 | 35F | Sarcoidosis | OU | 20–40 mg daily for 5 months | Insomnia, anxiety | Methotrexate 2.5–10 mg weekly for 30 months | Leukopenia in one patient | 0 mg | OD:CF OS: 20/400 | OD:20/50 OS: 20/20 | |
| | 41F | | OD | 10–40 mg daily for 2 months | Hyperglycaemia | Methotrexate 2.5–10 mg weekly for 36 months | | 18 mg | OD: CF | OD: 20/30 | |
| | 47F | | OU | 10–80 mg daily for 8 months | Mood swings, insomnia, weight gain, depression, alopecia | Methotrexate 7.5–15 mg weekly for 23 months | | 0 mg | OD: HM OS: 20/20 | OD: NLP OS: 20/25 | |
Bielory L | 1991 | 48 F | Orbital pseudotumor | OS | Unknown dose | 4 patients with weight gain, 2 patients with uncontrolled hyperglycaemia, 2 patients with hypertension | Cyclosporine A 2 mg/kg/day for an average of 16.5 months | Hypercholesterolaemia and hirsutism in unknown number of patients | Unclear | OS: 20/400 | OS: 20/20 | Weight gain, diabetes and hypertension resolved in all patients after corticosteroid dose was tapered. |
| | 38 M | Sarcoidosis | OU | | | | | | OD:20/20 OS: 20/25 | “Normal acuity” | |
| | 56 F | | OU | | | | | | OD:20/200 OS:20/200 | OD:CF OS:20/400 | |
| | 25 M | | OU | | | | | | OD:20/40 OS:20/200 | OD:20/30 OS:20/200 | |
Gelwan MJ | 1988 | 45 F | Sarcoidosis | OU | Unknown dose | Hypertension and diabetes | 4500 cGy of radiation then azathioprine 800 mg daily for 8 months | Unknown | 10 mg | OD:20/40 OS:20/100 | OD:20/25 OS:20/20 | |
| | 32 M | | OU | | Diabetes, cushingoid, glaucoma | 4500 cGy of radiation then azathioprine 200 mg daily for 5 months | None | 10 mg every other day | OD:20/40 OS:NLP | OD:20/60 OS:NLP | Diabetes and cushingoid features resolved |
| | 20 M | | OU | | Cushingoid | 4880 cGy of radiation then chlorambucil 6 mg daily for 6 months | Unknown | 7.5 mg | OD:20/20 OS:20/200 | OD:20/20 OS:CF | Poor compliance |
Gressel MG | 1983 | 21 F | Mixed connective tissue disease | OU | 40 mg daily | Cushingoid | Azathioprine for 7 months, then oral cyclophosphamide 100 mg daily for 5 months then chlorambucil 4 mg daily | Hemorrhagic cystitis and leukopenia on cyclophos-phamide | Unknown | OD:20/40 OS:20/25 | Unknown | Rapid progression despite treatment |
Purvin A | 1994 | 32 F | Neuroretinitis | OU | Unknown dose | Inefficacy | Azathioprine for 3 years | Unknown | Unknown | Unknown | OD:20/20 OS:20/80 | Recurrent attacks suppressed with azathioprine |
Kupersmith MJ | 1988 | 44 F | Autoimmune optic neuropathy | OD | 100 mg daily for 12 months | Corticosteroid intolerance or inefficacy | Chlorambucil 6 mg daily for 6.5 years | None | “lower” | OD: LP OS: 20/20 | OD: 20/25 OS: 20/20 | |
| | 42 F | | OU | 100 mg daily for 4 months | | Chlorambucil 6 mg daily for 6.5 years | None | “lower” | OD: NLP OS: LP | OD: NLP OS: 20/20 | |
| | 26 F | | OU | 100 mg daily for 3 months | | Cyclophosphamide 150 mg and Azathioprine 100 mg daily for 5.5 years | Pneumocystis pneumonia | “reduced” | ODHM OS: HM | OD: 20/25 OS: 20/25 | |
| | 26 F | | OU | 100 mg daily for 1.5 months | | Chlorambucil 6 mg and Azathioprine 75 mg daily for 6.5 years | Herpetic keratitis | “lower” | OD: CF OS: 20/300 | OD: 20/25 OS: 20/300 | |
| | 56 F | | OD | Unknown dose | | Azathioprine 125 mg daily for 6 months | None | 30 mg | OD: 20/400 OS: 20/20 | OD: 20/30 OS: 20/20 | |
| | 47 F | | OS | 20 mg daily for 1 months | | Azathioprine 50 mg daily for 1 week | None | 60 mg | OD: 20/20 OS: 20/400 | OD: 20/20 OS: 20/40 | Patient refused treatment after one week. |
| | 45 M | | OU | 60 mg daily for 1 months | | Chlorambucil 8 mg daily for 18 months | None | 5 mg | OD: LP OS: NLP | OD: 20/50 OS: LP | |
| | | | | | | Azathioprine 200 mg daily | | | | | |
| | | | | | | Chlorambucil 6 mg daily for over three years | | | | | |
| | 27 F | | OU | 80 mg daily for 1 months | | Chlorambucil 6 mg daily for 18 months | Agranulocytosis and sepsis | 10 mg | OD: 20/60 OS: NLP | OD: 20/20 OS: CF | Chlorambucil disontinued because of episode of sepsis. |
| | | | | | | Azathioprine 200 mg daily for 4 years | None | | | | |
Dutton JJ | 1982 | 44 F | Autoimmune retrobulbar optic neuritis | OU | Unknown dose | Unknown | Chlorambucil 6 mg daily for 2 years | Unknown | 0 mg | OD:20/80 OS:20/25 | OD:20/20 OS:20/20 | |
| | 26 F | | OU | | Cushingoid, depression | Chlorambucil 6 mg daily and azathioprine 75 mg daily for 1 year | | | OD:CF OS:CF | OD:20/30 OS:20/300 | |
| | 42 F | | OD | | Unknown | Chlorambucil 6 mg daily for 6 months | | | LP | 20/20 | |